Abstract:Ethnopharmacological relevance: Psoraleae Fructus (PF), a traditional Chinese medicine, has long been used to treat diseases such as cancer, osteoporosis and leukoderma. Psoralen and isopsoralen are main bioactive in-gredients of PF with anti-tumor, anti-inflammatory, estrogen-like neuroprotection, etc., meanwhile they are also representative hepatotoxic components of PF. Hepatic CYP1A2 has been reported to be the important metabolic enzymes involved in psoralen and isopsoralen-induced hepatotoxicity. However, the relationship between the hepatotoxicity and CYP1A2 expression, and the underlying mechanism of regulating CYP1A2 expression remain unclear. Aim of study: The aim of this study was to explore the associated mechanism between psoralen or isopsoralen induced hepatotoxicity and activated aryl hydrocarbon receptor (AhR)-mediated transcriptional induction of CYP1A2 in vitro and in vivo. Materials and methods: Psoralen and isopsoralen at different doses were treated on HepG2 cells (10, 25, 50, 100, 200 mu M for 2, 12, 24, 36, 48 h) and mice (20, 80, 160 mg/kg for 3, 7, 14 days) for different time, to assess the correlation of induced hepatotoxicity and CYP1A2 mRNA and protein expression in vivo and in vitro, as well as the effect on CYP1A2 enzyme activity evaluated by phenacetin metabolism. In addition, the potential mechanism of the regulation of CYP1A2 expression mediated by AhR was explored through nucleocytoplasmic shuttling, immunofluorescence, cellular thermal shift assay and molecular docking, etc. Results: Psoralen and isopsoralen induced cytotoxicity in HepG2 cells, and hepatomegaly, biochemicals disorder and tissue pathological impairment in mice, respectively in dose-and time-dependent manners. Simultaneously accompanied with elevated levels of CYP1A2 mRNA and protein in the same trend, and the CYP1A2 activity was remarkably inhibited in vitro but significantly elevated overall in vivo. Besides, psoralen and isopsoralen bound to AhR and activated translocation of AhR from the cytoplasm to the nucleus, leading to the transcriptional in-duction of target gene CYP1A2. Conclusions: Hepatotoxicities in HepG2 cells and mice aroused by psoralen and isopsoralen were related to the induction of CYP1A2 expression and activity, whose underlying mechanism might be psoralen or isopsoralen activated AhR translocation and induced increase of CYP1A2 transcriptional expression. Hopefully, these finding are conductive to propose an alert about the combined usage of psoralen or isopsoralen and AhR ligands or CYP1A2 substrates in clinical practice.

Psoralen Ameliorates Acetaminophen-Induced Acute Liver Injury by Inhibiting the Enzymatic Activity of CYP2E1

Psoralen and Isopsoralen from Psoraleae Fructus Aroused Hepatotoxicity Via Induction of Aryl Hydrocarbon Receptor-Mediated CYP1A2 Expression.

Psoralen Induced Liver Injury by Attenuating Liver Regenerative Capability

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

The mechanism of Psoralen and Isopsoralen hepatotoxicity as revealed by hepatic gene expression profiling in SD rats

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice

Protective Effect of 8-Methoxypsoralen against Acetaminophen-induced Acute Hepatic Injury in Mice

Transcriptomics and metabolomics reveal the role of CYP1A2 in psoralen/isopsoralen-induced metabolic activation and hepatotoxicity.

Psoralen induces hepatic toxicity through PERK and ATF6 related ER stress pathways in HepG2 cells

Mechanistic study of cytochrome P450 enzyme-mediated cytotoxicity of psoralen and isopsoralen

Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway

Psoralen induces liver injury and affects hepatic bile acids metabolism in female and male C57BL/6J mice

Psoralen Protects Neurons and Alleviates Neuroinflammation by Regulating Microglial M1/M2 Polarization Via Inhibition of the Fyn-PKCδ Pathway

4-Phenylbutyric acid suppresses psoralen-induced hepatotoxicity by inhibiting ERS and reestablishing mitochondrial fusion-fission balance in mice

Mechanism of Psoralen in Aggravating Hepatotoxicity Induced by CCl4 by Delaying Liver Regeneration

Phellinus Linteus Polysaccharides Mediates Acetaminophen-Induced Hepatotoxicity Via Activating AMPK/Nrf2 Signaling Pathways.

Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury

Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes.

Psoralen induces liver injuries through endoplasmic reticulum stress signaling in female mice

Recent advance in the role of peroxisome proliferator-activated receptor α in acetaminophen-induced hepatotoxicity